What are analysts' target prices for Aadi Bioscience (Aadi) stock?
5 equities research analysts have issued 1-year target prices for Aadi Bioscience's shares. Their AADI stock forecasts range from $30.00 to $51.00. On average, they predict Aadi Bioscience's share price to reach $43.50 in the next year. This suggests a possible upside of 215.4% from the stock's current price.
How many research reports have been published about Aadi Bioscience?
Aadi Bioscience has only been the subject of 1 research reports in the past 90 days. Sign-up to receive the latest news and ratings for Aadi Bioscience and its competitors with MarketBeat's FREE daily newsletter.
Does Aadi stock pay dividends?
Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price. AADI is not currently paying a regular dividend. The total number of shares of a security that have been sold short and not yet repurchased.
Should I buy or sell Aadi Bioscience stock right now?
5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aadi Bioscience in the last year. There are currently 5 buy ratin...
What is Aadi Bioscience's stock price forecast for 2022?
5 analysts have issued 12 month price targets for Aadi Bioscience's stock. Their forecasts range from $30.00 to $51.00. On average, they predict Aa...
How has Aadi Bioscience's stock price performed in 2022?
Aadi Bioscience's stock was trading at $24.15 at the beginning of 2022. Since then, AADI shares have decreased by 39.3% and is now trading at $14.6...
When is Aadi Bioscience's next earnings date?
Aadi Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast for Aa...
How were Aadi Bioscience's earnings last quarter?
Aadi Bioscience, Inc. (NASDAQ:AADI) issued its quarterly earnings results on Thursday, May, 12th. The company reported ($0.66) earnings per share (...
When did Aadi Bioscience's stock split? How did Aadi Bioscience's stock split work?
Shares of Aadi Bioscience reverse split before market open on Friday, August 27th 2021. The 1-15 reverse split was announced on Thursday, August 26...
Who are Aadi Bioscience's key executives?
Aadi Bioscience's management team includes the following people: Dr. Neil P. Desai Ph.D. , Founder, Pres, CEO, Sec. & Director (Age 57, Pay $1.2...
Who are some of Aadi Bioscience's key competitors?
Some companies that are related to Aadi Bioscience include Sierra Oncology (SRRA) , Madrigal Pharmaceuticals (MDGL) , BELLUS Health (BLUSF) , L...
What is Aadi Bioscience's stock symbol?
Aadi Bioscience trades on the NASDAQ under the ticker symbol "AADI."
Is Aadi Bioscience stock a Buy, Sell or Hold?
Aadi Bioscience stock has received a consensus rating of buy. The average rating score is and is based on 5 buy ratings, 1 hold ratings, and 0 sell...
What was the 52-week low for Aadi Bioscience stock?
The low in the last 52 weeks of Aadi Bioscience stock was 11.01. According to the current price, Aadi Bioscience is 127.70% away from the 52-week low.
What was the 52-week high for Aadi Bioscience stock?
The high in the last 52 weeks of Aadi Bioscience stock was 49.80. According to the current price, Aadi Bioscience is 28.23% away from the 52-week h...
What are analysts forecasts for Aadi Bioscience stock?
The 6 analysts offering price forecasts for Aadi Bioscience have a median target of 47.50, with a high estimate of 51.00 and a low estimate of 45.0...
What is Aadi Bioscience's stock price today?
When will Aadi Bioscience split?
One share of AADI stock can currently be purchased for approximately $17.35.
What is the P/E ratio of Aadi Bioscience?
Shares of Aadi Bioscience reverse split before market open on Friday, August 27th 2021. The 1-15 reverse split was announced on Thursday, August 26th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 25th 2021. An investor that had 100 shares of Aadi Bioscience stock prior to the reverse split would have 7 shares after the split.
Is Aadi Bioscience a buy?
The P/E ratio of Aadi Bioscience is -1.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Does Aadi Bioscience pay dividends?
Aadi Bioscience has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
What is dividend percentage?
Aadi Bioscience does not currently pay a dividend.
How long are futures trading delayed?
A company's dividend expressed as a percentage of its current stock price.
Who owns restricted shares of a company?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Source: FactSet
Does AADI pay dividends?
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
About AADI
AADI is not currently paying a regular dividend.
Analyst Forecast
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, ABI-009 (FYARRO) is a form of sirolimus bound to albumin.
Transparency is our policy. Learn how it impacts everything we do
According to 11 analysts, the average rating for AADI stock is "Buy." The 12-month stock price forecast is 49.73, which is an increase of 186.46% from the latest price.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
News
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
Trending Stocks
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers.
